Searched for
EMPAGLIFLOZIN TABLETS
New affordable diabetes drug Empagliflozin launched in IndiaSeveral domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly reduced prices follo...12 Mar, 2025, 04.58 PM IST- Indian pharma cos to launch cheaper diabetes medicine at 90% lower price soonDomestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the expiry of Boehrin...10 Mar, 2025, 04.05 PM IST
- Boehringer's Jardiance now gets CDSCO nod for chronic kidney diseaseThe Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of ...14 Feb, 2024, 10.39 PM IST
- Boehringer Ingelheim gets interim injunction against Dr. Reddy’s Labs, MSN Labs against copies of anti-diabetes drugIn a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...26 Oct, 2021, 03.44 PM IST
- MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.18 Oct, 2021, 07.50 PM IST
- Dr Reddy's Labs launches copy of BI drug; move may lead to legal battleUnder its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....18 Oct, 2021, 10.40 AM IST
- Lupin gets USFDA nod for generic diabetes drugThe company has received tentative approval for the product in multiple strengths from the United States Food and Drug Administration (USFD...07 Jan, 2021, 04.53 PM IST
- Alembic Pharmaceuticals gets USFDA's tentative approval for type 2 diabetes drugThe tentatively approved abbreviated new drug application (ANDA) is therapeutically equivalent to the reference listed drug product Glyxamb...27 Aug, 2020, 12.00 PM IST
- Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drugAlembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will de...20 Jul, 2020, 11.59 AM IST
- Trending stocks: Cadila Healthcare shares rise nearly 3%Shares of Cadila Healthcare traded 2.79 per cent up in trade at 10:55AM on Monday.04 May, 2020, 10.59 AM IST
- Cadila on the Moon on HCQ lift, awaits Covid-19 vaccine boosterThe drugmaker is one of the two largest manufacturers of hydroxychloroquine (HCQ).15 Apr, 2020, 01.02 PM IST
- Market Movers: L&T, Lupin, DRL gain; HDFC twins key drag; 50 stocks enter ‘buy’ zoneHDFC twins and Reliance Industries were among the biggest drags, but a jump in L&T after three ‘large’ order wins cushion the fall to some ...13 Apr, 2020, 05.51 PM IST
- Cadila Healthcare gains 2% on USFDA nod for Empagliflozin tabletsThe drug will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad.13 Apr, 2020, 03.44 PM IST
- Stocks in the news: DMart, HDFC, Dish TV, JSPL, Tata Consumer and GAILJSPL has bagged an order of 2,308 tonne head hardened rails from Kolkata Metro Rail Corporation.13 Apr, 2020, 07.21 AM IST
- Zydus Cadila gets USFDA nod to market generic type 2 diabetes drugThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Empagliflozin tablets, in...10 Apr, 2020, 04.33 PM IST
- Violation of drug price control order: Drug cos under NPPA lens for self-exemption from price capPricing watchdog has found that companies such as Lupin and Boehringer Ingelheim launched products bypassing the regulatory framework. The ...16 Dec, 2019, 08.31 PM IST
- Boehringer Igelheim aims for top slot with anti-diabetes drug launchWith Jardiance, BI has the advantage of significantly reducing cardiovascular risks associated with most patients with diabetes.25 Sep, 2015, 07.02 AM IST
Load More
